Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha

La hipertensión arterial es una patología muy importante en cuanto a que se considera un factor de riesgo cardiovascular muy relevante que conlleva a múltiples comorbilidades que comprometen diferentes órganos, sistemas y aparatos incluyendo al ojo. Por el hecho de ser una enfermedad sistémica, es u...

Full description

Autores:: Zambrano Ordoñez, José Daniel

Tipo de recurso:

Fecha de publicación:: 2017

Institución:: Universidad Autónoma de Bucaramanga - UNAB

Repositorio:: Repositorio UNAB

Idioma:: spa

id	UNAB2_8864a3c258b2bce114b43d064eb3a007
oai_identifier_str	oai:repository.unab.edu.co:20.500.12749/1785
network_acronym_str	UNAB2
network_name_str	Repositorio UNAB
repository_id_str
dc.title.spa.fl_str_mv	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha
dc.title.translated.eng.fl_str_mv	Prevalence of hypertensive retinopathy in the Chicamocha cohort - Chicamocha sub study
title	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha
spellingShingle	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha Hypertensive retinopathy Retina Ocular hypertension Medicine Ophthalmology Research Retinal diseases Blood pressure disorders Retinopatía hipertensiva Retina Hipertensión ocular Medicina Oftalmología Investigaciones Enfermedades de la retina Trastornos de la presión sanguínea
title_short	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha
title_full	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha
title_fullStr	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha
title_full_unstemmed	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha
title_sort	Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha
dc.creator.fl_str_mv	Zambrano Ordoñez, José Daniel
dc.contributor.advisor.spa.fl_str_mv	Tello Hernández, Alejandro
dc.contributor.author.spa.fl_str_mv	Zambrano Ordoñez, José Daniel
dc.contributor.cvlac.*.fl_str_mv	https://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0001009125
dc.contributor.googlescholar.*.fl_str_mv	https://scholar.google.es/citations?hl=es#user=puxZHKYAAAAJ
dc.contributor.scopus.*.fl_str_mv	https://www.scopus.com/authid/detail.uri?authorId=6603664598
dc.subject.keywords.eng.fl_str_mv	Hypertensive retinopathy Retina Ocular hypertension Medicine Ophthalmology Research Retinal diseases Blood pressure disorders
topic	Hypertensive retinopathy Retina Ocular hypertension Medicine Ophthalmology Research Retinal diseases Blood pressure disorders Retinopatía hipertensiva Retina Hipertensión ocular Medicina Oftalmología Investigaciones Enfermedades de la retina Trastornos de la presión sanguínea
dc.subject.lemb.spa.fl_str_mv	Retinopatía hipertensiva Retina Hipertensión ocular Medicina Oftalmología Investigaciones
dc.subject.proposal.none.fl_str_mv	Enfermedades de la retina Trastornos de la presión sanguínea
description	La hipertensión arterial es una patología muy importante en cuanto a que se considera un factor de riesgo cardiovascular muy relevante que conlleva a múltiples comorbilidades que comprometen diferentes órganos, sistemas y aparatos incluyendo al ojo. Por el hecho de ser una enfermedad sistémica, es uno de los contribuyentes prevenibles más importantes para desarrollar enfermedad y muerte.
publishDate	2017
dc.date.issued.none.fl_str_mv	2017
dc.date.accessioned.none.fl_str_mv	2020-06-26T20:01:42Z
dc.date.available.none.fl_str_mv	2020-06-26T20:01:42Z
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/masterThesis
dc.type.local.spa.fl_str_mv	Tesis
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/TM
dc.identifier.uri.none.fl_str_mv	http://hdl.handle.net/20.500.12749/1785
dc.identifier.instname.spa.fl_str_mv	instname:Universidad Autónoma de Bucaramanga - UNAB
dc.identifier.reponame.spa.fl_str_mv	reponame:Repositorio Institucional UNAB
url	http://hdl.handle.net/20.500.12749/1785
identifier_str_mv	instname:Universidad Autónoma de Bucaramanga - UNAB reponame:Repositorio Institucional UNAB
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Zambrano Ordoñez, José Daniel (2017). Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha. Bucaramanga (Santander, Colombia) : Universidad Autónoma de Bucaramanga UNAB 1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23. 2. Rogers AH. Hypertensive retinopathy, 113. In: Yanoff M, Duker JS, eds. Ophthalmology. 2nd ed. 2006;vol. 2:849e853. 3. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982;89(10):1132–45. 4. Saitoh M, Matsuo K, Momoto S, KondohT, Yanagawa T, Katoh Y, Hasegawa K. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension Intern Med 1998;37(7):576-80. 5. Daniels SR, Lipman MJ, Burke MJ, Loggie JM. Determinants of retinal vascular abnormalities in children and adolescents with essential hypertension. J Hum Hypertens. 1993;7(3):223-8 6. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmol 1982; 89: 1132–45. 7. Klein R, Sharrett AR, Klein BE, et al. Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 2000; 20: 1644–50. 8. Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 2004; 35: 1289–93. 9. Keith NM, Wagener HP, Barker NW. Some diff erent types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336–45. 10. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004; 351: 2310–17. 11. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol 1994; 112: 92–98. 12. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998; 116: 83–89. 13. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure.Invest Ophthalmol Vis Sci 2003; 44: 4644–50. 14. Sharrett AR, Hubbard LD, Cooper LS, et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150: 263–70. 15. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Impact of current and past blood pressure on retinal arteriolar diameter in an older population. J Hypertens 2004; 22: 1543–49. 16. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134–40. 17. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmol 2003; 110: 933–40. 18. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 2005; 65: 1005–09. 19. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293: 63–69. 20. Wong TY, Coresh J, Klein R, et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J Am Soc Neph 2004; 15: 2469–76. 21. Cuspidi C, Meani S, Salerno M, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 2095–102. 22. Saitoh M, Matsuo K, Nomoto S, et al. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension. Int Med 1998; 37: 576–80. 23. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–40. 24. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014;32:3–15. 25. Morishita R, Higaki J, Nakamura F, et al. Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat. Blood Pressure 1992; 3 (suppl): 41–47. 26. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertens 1984; 6: 158–62. 27. Organización Mundial de la Salud. Información general sobre la hipertensión en el mundo. Una enfermedad que mata en silencio, una crisis de salud pública mundial. Ginebra (Suiza). 2013 28. Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol. 2005 Dec;89(12):1646-54. 29. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998 Jan;116(1):83-9. 30. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134–40. 31. Del Brutto OH, Mera RM, Viteri EM, Pólit J, Ledesma EA, Cano JA, et al. Hypertensive retinopathy and cerebral small vessel disease in Amerindians living in rural Ecuador: The Atahualpa Project. Int J Cardiol. 2016 Sep 1;218:65-68. 32. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293: 63–69.
dc.rights.uri.*.fl_str_mv	http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.local.spa.fl_str_mv	Abierto (Texto Completo)
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.*.fl_str_mv	Atribución-NoComercial-SinDerivadas 2.5 Colombia
rights_invalid_str_mv	http://creativecommons.org/licenses/by-nc-nd/2.5/co/ Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 Atribución-NoComercial-SinDerivadas 2.5 Colombia
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.coverage.spa.fl_str_mv	Bucaramanga (Santander, Colombia)
dc.coverage.campus.spa.fl_str_mv	UNAB Campus Bucaramanga
dc.publisher.grantor.spa.fl_str_mv	Universidad Autónoma de Bucaramanga UNAB
dc.publisher.faculty.spa.fl_str_mv	Facultad Ciencias de la Salud
dc.publisher.program.spa.fl_str_mv	Especialización en Oftalmología
institution	Universidad Autónoma de Bucaramanga - UNAB
bitstream.url.fl_str_mv	https://repository.unab.edu.co/bitstream/20.500.12749/1785/1/2017_Tesis_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdf https://repository.unab.edu.co/bitstream/20.500.12749/1785/2/2017_Licencia_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdf https://repository.unab.edu.co/bitstream/20.500.12749/1785/3/2017_Tesis_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdf.jpg https://repository.unab.edu.co/bitstream/20.500.12749/1785/4/2017_Licencia_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdf.jpg
bitstream.checksum.fl_str_mv	f8251b912bdbeff3f98a5cb51b338a75 e62e179c0ba16363e44f25c45700531c 66f135203c217c920900052e952674f9 73701bb26c09dfe47087c760b6e3b90f
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional \| Universidad Autónoma de Bucaramanga - UNAB
repository.mail.fl_str_mv	repositorio@unab.edu.co
_version_	1814277277969547264
spelling	Tello Hernández, Alejandro7ae428b7-0b9b-4aff-9bbf-6940dcfd7cb5-1Zambrano Ordoñez, José Danielc4e96174-be1c-4868-9890-48babf0c6672-1https://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0001009125https://scholar.google.es/citations?hl=es#user=puxZHKYAAAAJhttps://www.scopus.com/authid/detail.uri?authorId=66036645982020-06-26T20:01:42Z2020-06-26T20:01:42Z2017http://hdl.handle.net/20.500.12749/1785instname:Universidad Autónoma de Bucaramanga - UNABreponame:Repositorio Institucional UNABLa hipertensión arterial es una patología muy importante en cuanto a que se considera un factor de riesgo cardiovascular muy relevante que conlleva a múltiples comorbilidades que comprometen diferentes órganos, sistemas y aparatos incluyendo al ojo. Por el hecho de ser una enfermedad sistémica, es uno de los contribuyentes prevenibles más importantes para desarrollar enfermedad y muerte.1. JUSTIFICACION 9 2. PLANTEAMIENTO DEL PROBLEMA 10 3. OBJETIVOS 11 3.1. OBJETIVO GENERAL 11 3.2. OBJETIVOS ESPECIFICOS 11 4. MARCO TEORICO 12 5. METODOLOGIA 22 5.1. TIPO DE ESTUDIO 22 5.2. POBLACION 22 5.3. CRITERIOS DE INCLUSION 22 5.4. CRITERIOS DE EXCLUSION 22 5.5. TAMAÑO DE LA MUESTRA 22 5.6. PROCEDIMIENTO 23 6. RESULTADOS 25 7. DISCUSION 32 8. BIBLIOGRAFIA 34EspecializaciónHypertension is a very important pathology in that it is considers a very relevant cardiovascular risk factor that leads to multiple comorbidities involving different organs, systems, and appliances including the eye. Due to the fact of being a systemic disease, it is one of the contributors preventable diseases to develop illness and death.Modalidad Presencialapplication/pdfspahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/Abierto (Texto Completo)info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Atribución-NoComercial-SinDerivadas 2.5 ColombiaPrevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio ChicamochaPrevalence of hypertensive retinopathy in the Chicamocha cohort - Chicamocha sub studyEspecialista en OftalmologíaBucaramanga (Santander, Colombia)UNAB Campus BucaramangaUniversidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludEspecialización en Oftalmologíainfo:eu-repo/semantics/masterThesisTesishttp://purl.org/redcol/resource_type/TMHypertensive retinopathyRetinaOcular hypertensionMedicineOphthalmologyResearchRetinal diseasesBlood pressure disordersRetinopatía hipertensivaRetinaHipertensión ocularMedicinaOftalmologíaInvestigacionesEnfermedades de la retinaTrastornos de la presión sanguíneaZambrano Ordoñez, José Daniel (2017). Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha. Bucaramanga (Santander, Colombia) : Universidad Autónoma de Bucaramanga UNAB1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23.2. Rogers AH. Hypertensive retinopathy, 113. In: Yanoff M, Duker JS, eds. Ophthalmology. 2nd ed. 2006;vol. 2:849e853.3. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982;89(10):1132–45.4. Saitoh M, Matsuo K, Momoto S, KondohT, Yanagawa T, Katoh Y, Hasegawa K. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension Intern Med 1998;37(7):576-80.5. Daniels SR, Lipman MJ, Burke MJ, Loggie JM. Determinants of retinal vascular abnormalities in children and adolescents with essential hypertension. J Hum Hypertens. 1993;7(3):223-86. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmol 1982; 89: 1132–45.7. Klein R, Sharrett AR, Klein BE, et al. Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 2000; 20: 1644–50.8. Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 2004; 35: 1289–93.9. Keith NM, Wagener HP, Barker NW. Some diff erent types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336–45.10. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 2004; 351: 2310–17.11. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol 1994; 112: 92–98.12. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998; 116: 83–89.13. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure.Invest Ophthalmol Vis Sci 2003; 44: 4644–50.14. Sharrett AR, Hubbard LD, Cooper LS, et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150: 263–70.15. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Impact of current and past blood pressure on retinal arteriolar diameter in an older population. J Hypertens 2004; 22: 1543–49.16. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134–40.17. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmol 2003; 110: 933–40.18. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 2005; 65: 1005–09.19. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293: 63–69.20. Wong TY, Coresh J, Klein R, et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J Am Soc Neph 2004; 15: 2469–76.21. Cuspidi C, Meani S, Salerno M, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 2095–102.22. Saitoh M, Matsuo K, Nomoto S, et al. Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension. Int Med 1998; 37: 576–80.23. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–40.24. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014;32:3–15.25. Morishita R, Higaki J, Nakamura F, et al. Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat. Blood Pressure 1992; 3 (suppl): 41–47.26. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertens 1984; 6: 158–62.27. Organización Mundial de la Salud. Información general sobre la hipertensión en el mundo. Una enfermedad que mata en silencio, una crisis de salud pública mundial. Ginebra (Suiza). 201328. Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol. 2005 Dec;89(12):1646-54.29. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998 Jan;116(1):83-9.30. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001; 358: 1134–40.31. Del Brutto OH, Mera RM, Viteri EM, Pólit J, Ledesma EA, Cano JA, et al. Hypertensive retinopathy and cerebral small vessel disease in Amerindians living in rural Ecuador: The Atahualpa Project. Int J Cardiol. 2016 Sep 1;218:65-68.32. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293: 63–69.ORIGINAL2017_Tesis_Jose_Daniel_Zambrano_Ordoñez.pdf2017_Tesis_Jose_Daniel_Zambrano_Ordoñez.pdfTesisapplication/pdf627890https://repository.unab.edu.co/bitstream/20.500.12749/1785/1/2017_Tesis_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdff8251b912bdbeff3f98a5cb51b338a75MD51open access2017_Licencia_Jose_Daniel_Zambrano_Ordoñez.pdf2017_Licencia_Jose_Daniel_Zambrano_Ordoñez.pdfLicenciaapplication/pdf710080https://repository.unab.edu.co/bitstream/20.500.12749/1785/2/2017_Licencia_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdfe62e179c0ba16363e44f25c45700531cMD52metadata only accessTHUMBNAIL2017_Tesis_Jose_Daniel_Zambrano_Ordoñez.pdf.jpg2017_Tesis_Jose_Daniel_Zambrano_Ordoñez.pdf.jpgIM Thumbnailimage/jpeg4467https://repository.unab.edu.co/bitstream/20.500.12749/1785/3/2017_Tesis_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdf.jpg66f135203c217c920900052e952674f9MD53open access2017_Licencia_Jose_Daniel_Zambrano_Ordoñez.pdf.jpg2017_Licencia_Jose_Daniel_Zambrano_Ordoñez.pdf.jpgIM Thumbnailimage/jpeg11474https://repository.unab.edu.co/bitstream/20.500.12749/1785/4/2017_Licencia_Jose_Daniel_Zambrano_Ordo%c3%b1ez.pdf.jpg73701bb26c09dfe47087c760b6e3b90fMD54open access20.500.12749/1785oai:repository.unab.edu.co:20.500.12749/17852023-03-15 10:18:24.816open accessRepositorio Institucional \| Universidad Autónoma de Bucaramanga - UNABrepositorio@unab.edu.co

Prevalencia de retinopatía hipertensiva en la cohorte Chicamocha - sub estudio Chicamocha

Publicaciones similares